Reliable knowledge on nan...
contactpointnano.ch helps with questions about nanomaterials A new contact point for start-ups, SMEs and industry bundles the scientific and regulatory expertise in the field of nanotechnology available
The MACRAMÉ Project, a 36-months research and innovation action, funded by the European Commission’s Horizon Europe Framework Programme, commenced its ambitious, collaborative workprogramme on the characterisation and
Swiss NanoConvention
Dr. Peter Wick represented contactpointnano and Empa at the Swiss NanoConvention in Neuchâtel (June 15-16, 2023). This year, the topics included nanoimaging, advanced manufacturing at nanoscale, smart
Questions about nanomater...
New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this
Nanomedicine: The Minuten...
Tiny particles that can fight cancer or that can easily pass through any interface within our body are a great promise for medicine. But there is little
Need help with the regist...
eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.
Country-scale calculation...
Plastic particles less than five millimeters in size, also known as microplastics, often settle far away from their point of origin. Empa researchers have now developed a
Clinam Summit in Basel
This year, the 14th European and Global Summit for Clinical Nanomedicine (CLINAM Summit) organized by the European Foundation for Clinical Nanomedicine will take place on 8-11 October
Microplastics and Nanopla...
Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Publications on Synthetic...
Action plan Synthetic Nanomaterials Final report 2 September 2020 (only available in German and French) Opportunities and Risks of Nanomaterials Journal of Nanobiotechnology, 2017 Opportunities and Risks